Management of oral anticoagulation after pulsed field ablation for atrial fibrillation: Insights from a multicenter study

Atrial FibrillationHeart Failure

Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Insights from the NCDR Atrial Fibrillation Ablation Registry

Heart Rhythm

Yousuf O, Akar J, Tan Z, Alkalbani M, Tasneem H, Steinberg BA, Hsu JC, Atwater B, Yang E, Spertus J, Calkins H, Freeman JV

doi: 10.1016/j.hrthm.2025.06.048

Atrial Fibrillation

Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation

N Engl J Med

Reichlin T, Kueffer T, Badertscher P, Jüni P, Knecht S, Thalmann G, Kozhuharov N, Krisai P, Jufer C, Maurhofer J, Heg D, Pereira TV, Mahfoud F, Servatius H, Tanner H, Kühne M, Roten L, Sticherling C, SINGLE SHOT CHAMPION Investigators

doi: 10.1056/NEJMoa2502280

Atrial Fibrillation

Pulsed Field Ablation for Persistent Atrial Fibrillation: 1-Year Results of ADVANTAGE AF

J Am Coll Cardiol

Reddy VY, Gerstenfeld EP, Schmidt B, Nair D, Natale A, Saliba W, Verma A, Sommer P, Metzner A, Turagam M, Weiner S, Champagne J, Garcio-Bolao I, Calkins H, Olson J, Issa Z, Winner M, Su W, Tomassoni G, Kim J, Hook B, Delurgio DB, Gibson DN, Daccarett M, Patel C, Bhalla K, Shehata M, Harding JD, Cheung JW, Raybuck JD, Roelke S, Schwartz T, Sutton BS, Mansour M, ADVANTAGE-AF Investigators

doi: 10.1016/j.jacc.2025.03.515

Atrial Fibrillation

Learning Curve and Procedural Efficiency of Zero-Fluoroscopy Pulsed-Field Ablation for Atrial Fibrillation

Heart Rhythm

Pérez-Pinzón J, Villarreal D, Ma M, Clarke JR, Ferro EG, Modi R, Adam O, Isaza N, Odozynski G, Samra G, Yopes M, Saad EB, Zimetbaum P, Haffajee CI, Yang S, Maher T, Kumar K, Shvilkin A, d'Avila A, Michaud GF, Tung P, Waks JW, Locke AH

doi: 10.1016/j.hrthm.2025.09.024

Atrial Fibrillation

Characterisation of Acute Residual Pulmonary Vein Connections Using Electroanatomical Mapping During Pulsed-Field Ablation of Atrial Fibrillation

Heart Rhythm

Mills MT, Sommer P, Day J, Demo H, Jewell CW, Trulock K, Bulava A, Tabrizi F, Braun M, Dirckx N, Wenzel E, Gupta D, Luther V

doi: 10.1016/j.hrthm.2025.06.037

Atrial Fibrillation

Impact of alternative efficacy endpoint definitions on reported outcomes after ablation of paroxysmal atrial fibrillation - insights from the COMPARE-CRYO study using continuous rhythm monitoring

Heart Rhythm

Iqbal SUR, Kueffer T, Knecht S, Badertscher P, Maurhofer J, Krisai P, Jufer C, Thalmann G, Heg D, Servatius H, Tanner H, Kühne M, Roten L, Sticherling C, Reichlin T, COMPARE-CRYO Trial investigators

doi: 10.1016/j.hrthm.2025.09.026

Thrombosis and StrokeTherapy and Intervention

Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial

Lancet

Veltkamp R, Korompoki E, Harvey KH, Harvey ER, Fießler C, Malzahn U, Rücker V, Montaner J, Caso V, Sibon I, Ringleb P, Halse O, Hügen K, Ullmann S, Schuhmann C, Todd GP, Haas K, Palà E, Debette S, Lachaize M, D'Aoust T, Enzinger C, Ropele S, Fandler-Höfler S, Haidegger M, Wang Y, Wafa HA, Cancelloni V, Mosconi MG, Lip GYH, Lane DA, Haefeli WE, Foerster KI, Wurmbach VS, Nielsen PB, Hajjar K, Müller P, Poli S, Purrucker J, Laible M, D'Anna L, Silva Y, de Torres Chacon R, Martínez-Sánchez P, Boulanger M, Norrving B, Paré G, Wachter R, Ntaios G, Wolfe CDA, Heuschmann PU, PRESTIGE-AF Consortium

doi: 10.1016/S0140-6736(25)00333-2

Atrial FibrillationThrombosis and Stroke

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials

Heart Rhythm

Kaisaier W, Xu Z, Guo L, Dong Y, Chen Y, Lip GYH, Zhu W

doi: 10.1016/j.hrthm.2025.07.051

Atrial Fibrillation

Hemorrhagic Stroke in Atrial Fibrillation: Trends in Incidence, Case Fatality, and Prior Oral Anticoagulation

J Am Heart Assoc

Tiili P, Lehto M, Halminen O, Haukka J, Lehtonen O, Linna M, Satopää J, Korja M, Niemelä M, Kinnunen J, Aro AL, Mustonen P, Hartikainen J, Airaksinen KEJ, Putaala J, FinACAF study group

doi: 10.1161/JAHA.124.040360

Related content

Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Insights from the NCDR Atrial Fibrillation Ablation Registry

Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation

Pulsed Field Ablation for Persistent Atrial Fibrillation: 1-Year Results of ADVANTAGE AF

Learning Curve and Procedural Efficiency of Zero-Fluoroscopy Pulsed-Field Ablation for Atrial Fibrillation

Characterisation of Acute Residual Pulmonary Vein Connections Using Electroanatomical Mapping During Pulsed-Field Ablation of Atrial Fibrillation

Impact of alternative efficacy endpoint definitions on reported outcomes after ablation of paroxysmal atrial fibrillation - insights from the COMPARE-CRYO study using continuous rhythm monitoring

Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials

Hemorrhagic Stroke in Atrial Fibrillation: Trends in Incidence, Case Fatality, and Prior Oral Anticoagulation